What is PharmEasy?
PharmEasy operates as a comprehensive online pharmacy and healthcare platform, providing a wide range of pharmaceutical products and health services to consumers. The company aims to bridge the gap in healthcare accessibility by leveraging technology to offer convenient and affordable solutions. Its business model focuses on efficient supply chain management and a user-friendly digital interface, positioning it as a key player in India's rapidly evolving digital health landscape.
How much funding has PharmEasy raised?
PharmEasy has raised a total of $1.5B across 8 funding rounds:
Series A
$5M
Series B
$18M
Series C
$77.4M
Series D
$220M
Multiple Rounds
$1B
Other Financing Round
$216M
Series A (2015): $5M, investors not publicly disclosed
Series B (2017): $18M led by Aarin Capital, Bessemer Venture Partners, and Orios Venture Partners
Series C (2018): $77.4M supported by Nandan Nilekani, Think Investments, F-Prime Capital, Bessemer Venture Partners, Trifecta Capital, Orios Venture Partners, JM Financial, Fundamentum, Manipal Group, and Eight Roads Ventures India
Series D (2019): $220M featuring Temasek
Series E (2021): $350M backed by Eight Roads Services, Temasek, LGT Lightrock, CDPQ, Prosus Ventures, TPG, and Think Investments
Unspecified (2021): $300M with participation from Temasek, TPG, and Kotak Group
Other Financing Round (2021): $350M led by Amansa Capital and ApaH Capital Management
Other Financing Round (2024): $216M, investors not publicly disclosed
Key Investors in PharmEasy
Temasek
Temasek is a global investment company headquartered in Singapore, known for its generational investment approach and focus on making a difference with tomorrow in mind.
TPG
TPG is a global investment firm managing alternative assets and supporting business growth across diverse industries, including private equity, credit, and real estate.
Amansa Capital
Amansa Capital Pte. Ltd. is a Singapore-based fund management company specializing in absolute returns over the long term, with a strong emphasis on investment opportunities in India.
What's next for PharmEasy?
With substantial backing from major investors, PharmEasy is poised for accelerated growth and market penetration. The recent strategic investment suggests a focus on expanding its service offerings, enhancing its technological infrastructure, and potentially exploring new geographic markets. The company's trajectory indicates a move towards solidifying its leadership in the online healthcare segment, with future developments likely centered on strategic partnerships, service diversification, and continued digital innovation to meet the growing demand for accessible healthcare solutions.
See full PharmEasy company page
